#FDA Approves #Nivolumab/#Ipilimumab Plus Chemotherapy for First-Line Treatment of Metastatic or Recurrent #NSCLC


https://ascopost.com/news/may-2020/fda-approves-nivolumabipilimumab-plus-chemotherapy-for-first-line-treatment-of-metastatic-or-recurrent-nsclc/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.